AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
This Quarter Return
+12.94%
1 Year Return
+47.76%
3 Year Return
+48.37%
5 Year Return
–
10 Year Return
–
AUM
$273M
AUM Growth
+$273M
(+22%)
Cap. Flow
+$32.1M
Cap. Flow
% of AUM
11.76%
Top 10 Holdings %
Top 10 Hldgs %
21.2%
Holding
121
New
13
Increased
46
Reduced
53
Closed
9
Top Buys
| 1 |
Marvell Technology
MRVL
|
$3.61M |
| 2 |
SolarEdge
SEDG
|
$3.4M |
| 3 |
Veeva Systems
VEEV
|
$3.31M |
| 4 |
Quanterix
QTRX
|
$2.99M |
| 5 |
SoFi Technologies
SOFI
|
$2.65M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$2.86M |
| 2 |
Guardant Health
GH
|
$2.75M |
| 3 |
Illumina
ILMN
|
$2.18M |
| 4 |
Moderna
MRNA
|
$2.16M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$2.05M |
Sector Composition
| 1 | Technology | 44.69% |
| 2 | Healthcare | 32.32% |
| 3 | Financials | 8.45% |
| 4 | Industrials | 7.11% |
| 5 | Consumer Discretionary | 3.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCT
101
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $913K | 0.33% |
20,986
+2,634
| +14% | +$115K |
|
102
Biogen
BIIB
$20.9B
| $912K | 0.33% |
2,633
-134
| -5% | -$46.4K |
|
103
Emergent Biosolutions
EBS
$434M
| $889K | 0.33% |
14,114
-1,361
| -9% | -$85.7K |
|
104
Seres Therapeutics
MCRB
$171M
| $843K | 0.31% |
35,354
+13,592
| +62% | +$324K |
|
105
GoHealth
GOCO
$81.2M
| $841K | 0.31% |
75,018
-52,575
| -41% | -$589K |
|
106
Lufax Holding
LU
$2.75B
| $811K | 0.3% |
71,754
+6,238
| +10% | +$70.5K |
|
|
CELL
107
DELISTED
PhenomeX Inc. Common Stock
CELL
| $786K | 0.29% |
+17,551
| New | +$786K |
|
108
Fastly
FSLY
$1.09B
| $725K | 0.27% |
12,160
+125
| +1% | +$7.45K |
|
|
NSTG
109
DELISTED
NanoString Technologies, Inc.
NSTG
| $692K | 0.25% |
+10,677
| New | +$692K |
|
110
Guidewire Software
GWRE
$18.3B
| $682K | 0.25% |
6,046
+495
| +9% | +$55.8K |
|
111
Nurix Therapeutics
NRIX
$720M
| $626K | 0.23% |
+23,611
| New | +$626K |
|
112
American Well
AMWL
$109M
| $377K | 0.14% |
29,940
+1,080
| +4% | +$13.6K |
|
113
BioMarin Pharmaceuticals
BMRN
$11.4B
| – | – |
-7,429
| Closed | -$561K |
|
|
114
Illumina
ILMN
$15.3B
| – | – |
-5,670
| Closed | -$2.18M |
|
115
Ionis Pharmaceuticals
IONS
$9.62B
| – | – |
-20,146
| Closed | -$906K |
|
116
Regeneron Pharmaceuticals
REGN
$61.9B
| – | – |
-2,067
| Closed | -$978K |
|
117
Regenxbio
RGNX
$471M
| – | – |
-60,033
| Closed | -$2.05M |
|
|
118
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-13,319
| Closed | -$2.86M |
|
|
CBAY
119
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-111,525
| Closed | -$506K |
|
|
PFPT
120
DELISTED
Proofpoint, Inc.
PFPT
| – | – |
-9,347
| Closed | -$1.18M |
|